-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OFmuCTeaM0xwgX6hjQ9Bn03emrR4nXQC9aECrHkIFRK4opeR2NkqAp8frNJ02yNW JEyMIGiJ6rJ2ANpVIBDPDw== 0001017920-98-000079.txt : 19981209 0001017920-98-000079.hdr.sgml : 19981209 ACCESSION NUMBER: 0001017920-98-000079 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CRYOMEDICAL SCIENCES INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: SEC FILE NUMBER: 000-18170 FILM NUMBER: 98765300 BUSINESS ADDRESS: STREET 1: 1300 PICARD DR STE 102 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 3014177070 MAIL ADDRESS: STREET 1: 1300 PICCARD DRIVE SUITE 102 CITY: ROCKVILLE STATE: MD ZIP: 20850 DEFA14A 1 December 8, 1998 Dear Stockholder: This letter is a reminder to send in your Proxy in connection with the Special Meeting of Stockholders to be held December 16, 1998. IF YOU DO NOT SEND IN YOUR PROXY, YOUR VOTE CANNOT BE COUNTED TOWARDS THE ESTABLISHMENT OF A QUORUM AND FOR THE TRANSACTION OF BUSINESS AT THE MEETING. There are 33,454,302 shares of Common Stock issued and outstanding, each of which has one vote on each Proposal to be presented at the Meeting, and 128 shares of Series E Convertible Preferred Stock, each of which has 10,000 votes on each Proposal to be presented at the Meeting. The holders of Common Stock and the holders of Preferred Stock will vote together on the Proposals as if they held one class of stock. Therefore, there are an aggregate of 34,734,302 votes to be cast at the Meeting. The holders of stock representing a majority of the votes (17,367,152) entitled to be cast at the Meeting, present in person or by proxy, is required for a quorum to transact business at the Meeting and any adjournments thereof. The same number of votes is required to approve a number of the Proposals to be voted on at the Meeting. To date, the Company has received Proxies representing only approximately 10,500,000 shares, better than 90% of which have voted in favor of all of the Proposals. IT IS IMPERATIVE THAT EACH STOCKHOLDER SEND IN HIS OR HER PROXY SO THAT BUSINESS MAY BE TRANSACTED AT THE MEETING. As set forth in the Notice of Meeting, the purpose of the Meeting is to ratify and approve each of the matters contained in a Plan of Recapitalization and Financing (the "Plan") adopted by the Company's Board of Directors. Each matter is individually itemized on the proxy voting card. In order for the Plan to be "approved," all six of these matters must be approved. If you elect to abstain or vote against any one of these matters your overall vote will be considered to be "against" the Plan. It is imperative that we get stockholder approval of the Plan. As disclosed in the Proxy Statement, THE FAILURE TO APPROVE EACH OF THE PROPOSALS CONTAINED IN THE PLAN COULD HAVE A MATERIAL ADVERSE EFFECT ON THE BUSINESS AND FINANCIAL CONDITION OF THE COMPANY. We look forward to your support. Sincerely, /s/ Richard J. Reinhart Richard J. Reinhart, Ph.D. President and CEO -----END PRIVACY-ENHANCED MESSAGE-----